Aufa, Syafiq, and Jufriady Ismy. “Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer”. Indonesian Journal of Global Health Research, vol. 8, no. 6, Sept. 2026, pp. 89-98, doi:10.37287/ijghr.v8i6.2572.